In focus · trending topic

FDA Fast Track Designation

1 stories · following the connections

Cognition Therapeutics Receives Fast Track Designation from U.S. FDA for First-in-Class Alzheimer’s Candidate, CT1812

By Nasdaq OMXOct 16, 2017, 12:00 PM UTC